By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But ...
American EV automaker Rivian has submitted a slew of exciting new patent applications with the USPTO this week.
3don MSN
Some new drugs aren't actually 'new': Pharmaceutical companies exploit patents and raise prices
Pharmaceutical innovation saves lives. But not every "new" drug is truly new.
Innovation has always played a defining role in sports. From new types of equipment to advanced training methods and ...
According to the latest information from the National Intellectual Property Administration, the State Grid Shanghai Electric Power Company has jointly obtained a patent with Tongji University titled ...
The patent obtained by H3C Data focuses on implementing QoS directory traffic control within a distributed file system. In today’s era of big data, the demand for data storage has exploded, making ...
Genmab A/S is a solid buy with undervalued stock, robust royalties, and blockbuster ADC potential. Click for my look at GMAB ...
The report highlights opportunities in LNG peak shaving for power generation, grid stability, and industrial demand management. Significant growth in patent filings since 2016, led by China, points to ...
Sauvegarder Investment Management ("SIM IP"), a global leader in intellectual property-based investment and monetization, is ...
Juristat, a leading provider of patent prosecution solutions, today announced the launch of its Appeals Module. The new ...
Jazz Pharmaceuticals' growth is anchored by Xywav and Epidiolex, both generating robust sales and supporting future oncology ...
The Controller General of Patents, Designs and Trademarks (CGPDTM), the Indian Patent Office, has annulled the patent granted to Novartis for its cardiac drug Vymada, also sold internationally as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback